Exact Mass: 632.4660468000001
Exact Mass Matches: 632.4660468000001
Found 500 metabolites which its exact mass value is equals to given mass value 632.4660468000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Caldariellaquinol
C39H68O2S2 (632.4660468000001)
A 1-benzothiophene that is 1-benzothiophene-4,7-diol bearing additional methylthio and 3,7,11,15,19,23-hexamethyltetracosyl substituents at positions 5 and 6 respectively
PA(16:1(9Z)/15:0)
PA(16:1(9Z)/15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:1(9Z)/15:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
DG(15:0/PGJ2/0:0)
DG(15:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/15:0/0:0)
DG(PGJ2/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(15:0/0:0/PGJ2)
DG(15:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/0:0/15:0)
DG(PGJ2/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)
DG(16:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/16:0/0:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))
DG(16:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/16:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)
DG(16:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/16:0/0:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))
DG(16:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/16:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)
DG(16:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/16:0/0:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))
DG(16:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/16:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)
DG(16:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/16:0/0:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))
DG(16:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/16:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/16:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/16:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)
DG(16:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/16:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))
DG(16:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/16:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/16:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/16:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/16:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/16:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/16:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/16:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)
DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/16:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))
DG(16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/16:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)
DG(16:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/16:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))
DG(16:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/16:0)
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)
DG(16:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/16:0/0:0)
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))
DG(16:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/16:0)
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)
DG(16:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/16:0/0:0)
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))
DG(16:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/16:0)
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)
DG(16:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/16:0/0:0)
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))
DG(16:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/16:0)
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/PGJ2/0:0)
DG(a-15:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/a-15:0/0:0)
DG(PGJ2/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/0:0/PGJ2)
DG(a-15:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/0:0/a-15:0)
DG(PGJ2/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/PGJ2/0:0)
DG(i-15:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/i-15:0/0:0)
DG(PGJ2/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/0:0/PGJ2)
DG(i-15:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/0:0/i-15:0)
DG(PGJ2/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)
DG(i-16:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-16:0/0:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))
DG(i-16:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-16:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)
DG(i-16:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-16:0/0:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))
DG(i-16:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-16:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)
DG(i-16:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/i-16:0/0:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))
DG(i-16:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-16:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)
DG(i-16:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/i-16:0/0:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))
DG(i-16:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-16:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)
DG(i-16:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-16:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))
DG(i-16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-16:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)
DG(i-16:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-16:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))
DG(i-16:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-16:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)
DG(i-16:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-16:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))
DG(i-16:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-16:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
(2S,3R,4E)-2-N-(13-methyltetradecanoyl)-4-hexadecasphingenyl-1-phosphoethanolamine
C34H69N2O6P (632.4892983999999)
PE-Cer(d16:1/16:0)
C34H69N2O6P (632.4892983999999)
bacteriohopane-32,33-diol-34,35-dicarbamate
C37H64N2O6 (632.4764124000001)
CerPE 32:1;O2
C34H69N2O6P (632.4892983999999)
1-Heptadecanoyl-2-myristoyl-sn-glycero-3-phosphate(2-)
[(E)-3-hydroxy-2-(octanoylamino)henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-(henicosanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-(heptanoylamino)-3-hydroxydocos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(pentanoylamino)tetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(propanoylamino)hexacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(icosanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-(hexanoylamino)-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-acetamido-3-hydroxyheptacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(nonanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-(butanoylamino)-3-hydroxypentacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-(hexadecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(undecanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-(heptadecanoylamino)-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(nonadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-(decanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(octadecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] icosanoate
[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tricosanoate
[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] henicosanoate
[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate
[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate
[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate
[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] docosanoate
[1-Dodecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate
[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate
[1-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] tetradecanoate
[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(tetradecanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(tridecanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-2-(dodecanoylamino)-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E)-3-hydroxy-2-(pentadecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexacos-15-enoate
(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (Z)-heptadec-9-enoate
(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate
[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] heptadecanoate
[2-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] hexadecanoate
[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] octadecanoate
(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate
(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-octadec-9-enoate
[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-icos-11-enoate
(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexadec-9-enoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-octadec-9-enoate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
N-(tetradecanoyl)-4E-pentadecasphingenine-1-phosphocholine
C34H69N2O6P (632.4892983999999)
N-(tridecanoyl)-4E-hexadecasphingenine-1-phosphocholine
C34H69N2O6P (632.4892983999999)
N-(dodecanoyl)-4E-heptadecasphingenine-1-phosphocholine
C34H69N2O6P (632.4892983999999)
N-(pentadecanoyl)-4E-tetradecasphingenine-1-phosphocholine
C34H69N2O6P (632.4892983999999)
[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] heptadecanoate
[(E,2R,3S)-2-(decanoylamino)-3-hydroxynonadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-heptadec-9-enoate
[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-icos-13-enoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-octadec-4-enoate
[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-heptadec-9-enoate
[(E,2S,3R)-3-hydroxy-2-(tridecanoylamino)hexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-octadec-4-enoate
[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate
[(2R)-2-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] pentadecanoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-octadec-11-enoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-octadec-7-enoate
[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] hexadecanoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-octadec-7-enoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-octadec-6-enoate
[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-octadec-9-enoate
[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]propyl]-trimethylazanium
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-octadec-13-enoate
[(E,2S,3R)-3-hydroxy-2-(pentadecanoylamino)tetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxyheptadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoate
[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-octadec-6-enoate
[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-hexadec-9-enoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-octadec-11-enoate
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]propyl]-trimethylazanium
[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] hexadecanoate
[1-carboxy-3-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-icos-11-enoate
[(2S)-1-dodecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate
[(2S)-2-dodecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tridecanoate
[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate
[(2S)-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] tetradecanoate
[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] heptadecanoate
[(E,2R,3S)-2-(decanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-icos-11-enoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-octadec-13-enoate
2-[[(2R)-3-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] octadec-17-enoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-icos-13-enoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] octadec-17-enoate
[(E,2S,3R)-3-hydroxy-2-(tetradecanoylamino)pentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C34H69N2O6P (632.4892983999999)
[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate
[(2S)-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] tetradecanoate
[1-carboxy-3-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium
[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexadec-9-enoate
[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexadec-7-enoate
2-[hydroxy-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-decanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[3-nonanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
2-[[3-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-heptanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-decoxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-heptanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-hexanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-[(Z)-tridec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
N-(octadecanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine
C34H69N2O6P (632.4892983999999)
An N-acyl-C14 sphingosine 1-phosphoethanolamine where the acyl group is octadecanoyl.
1-Heptadecanoyl-2-myristoyl-sn-glycero-3-phosphate(2-)
A 1,2-diacyl-sn-glycerol 3-phosphate(2-) in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and myristoyl respectively.
SM(29:1)
C34H69N2O6P (632.4892983999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MGMG(26:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePA(29:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1s,1'r,4's,5'r,9's,10's,13'r)-3-{2-[(1r,4as,5s,8as)-5-(methoxycarbonyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid
(2s)-2-hydroxy-3-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}propyl pentacosanoate
(2s,3r,26s,27s)-2,27-diamino-3-hydroxy-26-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-11-one
2,27-diamino-3-hydroxy-26-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-11-one
4-{2-[5-(methoxycarbonyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid
(2r,3r,26r,27r)-2,27-diamino-3-hydroxy-26-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-11-one
(1s,2s,3as,3bs,5ar,6r,7s,9r,9as,9bs,10r,11as)-9-(acetyloxy)-1-[(1s)-1-(dimethylamino)ethyl]-2,6-dihydroxy-7-[(3s)-3-isopropyl-2-oxoazetidin-1-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-10-yl 3-methylbutanoate
C36H60N2O7 (632.4400290000001)
methyl (1s,4as,5r,8as)-5-{3-[(1r)-4-{2-[(1r,4as,5s,8as)-5-(methoxycarbonyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}cyclohex-3-en-1-yl]but-3-en-1-yl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
2-hydroxy-3-{[3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]oxy}propyl pentacosanoate
3-{2-[5-(methoxycarbonyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid
methyl (1s,4r,5r,9r,10r,12r,16r,17s,22s,24r,26r,28s)-26-isopropyl-28-methoxy-5,9,13,17,19,19-hexamethyl-23,29-dioxooctacyclo[14.11.2.0¹,¹⁰.0⁴,⁹.0¹²,²⁴.0¹⁶,²⁴.0¹⁷,²².0²⁶,²⁸]nonacos-13-ene-5-carboxylate
methyl 5-[3-(4-{2-[5-(methoxycarbonyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}cyclohex-3-en-1-yl)but-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
n-[(2s,3r,4e)-1-{[2-aminoethoxy(hydroxy)phosphoryl]oxy}-3-hydroxytetradec-4-en-2-yl]octadecanimidic acid
C34H69N2O6P (632.4892983999999)